首页> 外文OA文献 >Dizajniranje i vrednovanje okularnih umetaka moksifloksacin hidroklorida
【2h】

Dizajniranje i vrednovanje okularnih umetaka moksifloksacin hidroklorida

机译:盐酸莫西沙星眼片的设计与评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of the present investigation was to prepare and evaluate ocular inserts of moxifloxacin. An ocular insert was made from an aqueous dispersion of moxifloxacin, sodium alginate, polyvinyl alcohol, and dibutyl phthalate by the film casting method. The ocular insert (5.5 mm diameter) was cross-linked by CaCl2 and was coated with Eudragit S-100, RL-100, RS-100, E-100 or Eudragit L-100. The in vitro drug drainage/permeation studies were carried out using an all-glass modified Franz diffusion cell. The drug concentration and mucoadhesion time of the ocular insert were found satisfactory. Cross-linking and coating with polymers extended the drainage from inserts. The cross-linked ocular insert coated with Eudragit RL-100 showed maximum drug permeation compared to other formulations.
机译:本研究的目的是准备和评估莫西沙星的眼用插入物。通过膜流延法由莫西沙星,海藻酸钠,聚乙烯醇和邻苯二甲酸二丁酯的水分散体制成眼用插入物。眼插入物(直径5.5mm)通过CaCl 2交联,并涂覆有Eudragit S-100,RL-100,RS-100,E-100或Eudragit L-100。使用全玻璃修饰的Franz扩散池进行体外药物引流/渗透研究。眼插入物的药物浓度和粘膜粘着时间令人满意。交联和聚合物涂层延长了插件的排水。与其他制剂相比,涂有Eudragit RL-100的交联眼用插入物显示出最大的药物渗透性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号